Document Detail

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
MedLine Citation:
PMID:  2138525     Owner:  NLM     Status:  MEDLINE    
An acute myocardial infarction, particularly one that is large and transmural, can produce alterations in the topography of both the infarcted and noninfarcted regions of the ventricle. This remodeling can importantly affect the function of the ventricle and the prognosis for survival. In the early period, infarct expansion has been recognized by echocardiography as a lengthening of the noncontractile region. The noninfarcted region also undergoes an important lengthening that is consistent with a secondary volume-overload hypertrophy and that can be progressive. The extent of ventricular enlargement after infarction is related to the magnitude of the initial damage to the myocardium and, although an increase in cavity size tends to restore stroke volume despite a persistently depressed ejection fraction, ventricular dilation has been associated with a reduction in survival. The process of ventricular enlargement can be influenced by three interdependent factors, that is, infarct size, infarct healing, and ventricular wall stresses. A most effective way to prevent or minimize the increase in ventricular size after infarction and the consequent adverse effect on prognosis is to limit the initial insult. Acute reperfusion therapy has been consistently shown to result in a reduction in ventricular volume. The reestablishment of blood flow to the infarcted region, even beyond the time frame for myocyte salvage, has beneficial effects in attenuating ventricular enlargement. The process of scarification can be interfered with during the acute infarct period by the administration of glucocorticosteroids and nonsteroidal antiinflammatory agents, which result in thinner infarcts and greater degrees of infarct expansion. Modification of distending or deforming forces can importantly influence ventricular enlargement. Even short-term augmentations in afterload have deleterious long-term effects on ventricular topography. Conversely, judicious use of nitroglycerin seems to be associated with an attenuation of infarct expansion and long-term improvement in clinical outcome. Long-term therapy with an angiotensin converting enzyme inhibitor can favorably alter the loading conditions on the left ventricle and reduce progressive ventricular enlargement as demonstrated in both experimental and clinical studies. With the former therapy, this attenuation of ventricular enlargement was associated with a prolongation in survival. The long-term clinical consequences of long-term angiotensin converting enzyme inhibitor therapy after myocardial infarction is currently being evaluated. Although studies directed at attenuating left ventricular remodeling after infarction are in the early stages, it does seem that this will be an important area in which future research might improve long-term outcome after infarction.
M A Pfeffer; E Braunwald
Related Documents :
6653645 - Systolic time intervals during long-term beta-blockade with alprenol in ischaemic heart...
17420995 - Coronary artery fistulas: how to manage them.
23264785 - Echocardiographic assessment of inappropriate left ventricular mass and left ventricula...
17254595 - Short- and long-term prognostic value of the corrected qt interval in the non-st-elevat...
10328605 - Update on mechanical revascularization in acute myocardial infarction: which role and w...
10699695 - Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Circulation     Volume:  81     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1990 Apr 
Date Detail:
Created Date:  1990-05-02     Completed Date:  1990-05-02     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1161-72     Citation Subset:  AIM; IM; S    
Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adaptation, Physiological
Anti-Inflammatory Agents / therapeutic use
Cardiomegaly / etiology,  physiopathology
Cicatrix / etiology,  prevention & control
Heart / physiopathology*
Heart Ventricles
Myocardial Infarction / complications,  pathology,  physiopathology*
Myocardium / pathology
Reg. No./Substance:
0/Anti-Inflammatory Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during c...
Next Document:  Sensitive enzyme immunoassay for human Cu/Zn superoxide dismutase.